BMC Cancer
- TAN R, Zhu X, Sun Y, Yang S, et al
The association of HBV infection and head and neck cancer: a systematic review
and meta-analysis.
BMC Cancer. 2024;24:225.
Dig Dis Sci
- CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on
Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
Hepatology
- ENGELSKIRCHER SA, Chen PC, Strunz B, Oltmanns C, et al
Impending hepatocellular carcinoma diagnosis in cirrhotic patients after HCV cure
features a natural killer cell signature.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000804.
- YAMAZAKI T, Kouno T, Hsu CL, Hartmann P, et al
Serum aryl hydrocarbon receptor activity is associated with survival in patients
with alcohol-associated hepatitis.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000777.
- PAPATHERODORIDIS G, Lampertico P
Hepatocellular carcinoma risk in HBeAg-positive chronic hepatitis B patients
under long-term nucleos(t)ide analogue therapy: New insights from Asia.
Hepatology. 2024 Feb 16. doi: 10.1097/HEP.0000000000000796.
J Hepatol
- SHEEHAN Y, Grebely J, Lloyd AR
Reply to: " 'One-stop-shop' point-of-care hepatitis C RNA testing intervention in
the prison - some issues".
J Hepatol. 2024;80:e107-e108.
J Med Virol
- LIU Y, Kim ES, Guo H
Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral
microbiota and immune microenvironment signatures.
J Med Virol. 2024;96:e29485.
J Viral Hepat
- IQBAL HS, Gunaratne MP, Loeb TA, Pradeep A, et al
High prevalence of hepatitis B virus among MSM living with HIV in India.
J Viral Hepat. 2024 Feb 22. doi: 10.1111/jvh.13929.
- WOLFSON-STOFKO B, Hirode G, Vanderhoff A, Karkada J, et al
Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy
clinics in Ontario, Canada.
J Viral Hepat. 2024 Feb 22. doi: 10.1111/jvh.13931.
- FRYE K, Davis A, Darby R, McDaniel K, et al
A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a
safety-net hospital.
J Viral Hepat. 2024 Feb 18. doi: 10.1111/jvh.13913.
- WALTER LA, Prados M, Lloyd A, Sontheimer S, et al
Birth cohort-specific consideration in an Emergency Department Hepatitis C
Testing Programme: A description of age-related characteristics and outcomes.
J Viral Hepat. 2024 Feb 17. doi: 10.1111/jvh.13930.
- TULLY DC, Power KA, Sarette J, Stopka TJ, et al
Validation of dried blood spots for capturing hepatitis C virus diversity for
genomic surveillance.
J Viral Hepat. 2024 Feb 16. doi: 10.1111/jvh.13924.
Lancet
- HUANG S, Zhang X, Su Y, Zhuang C, et al
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year
results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2024 Feb 19:S0140-6736(23)02234-1. doi: 10.1016/S0140-6736(23)02234.
Transplantation
- THULUVATH PJ, Amjad W, Russe-Russe J, Li F, et al
The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the
DAA Era.
Transplantation. 2024 Feb 23. doi: 10.1097/TP.0000000000004953.
Vaccine
- KOCHHAR S, Assis DN, Mack C, Izurieta HS, et al
Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for
data collection, analysis, and presentation of immunisation safety data.
Vaccine. 2024 Feb 16:S0264-410X(24)00021-5. doi: 10.1016/j.vaccine.2024.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016